PET/CT scan test for high-risk breast cancer
Part of Cancer clinical trials.
This trial studies how an FDG PET/CT scan (a special imaging test that looks for active cancer activity) can be used in people with high-risk primary or recurring breast cancer. It may help doctors better identify areas of concern and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk breast cancer, either new (primary) or coming back (recurrent).
- You are a non-pregnant woman and older than 18 years.
- You are not currently receiving active treatment for a different cancer.
- Your general functioning is good: ECOG 0, 1, or 2 (you can do most daily activities).
- You should not be pregnant at the time of the scan (pregnancy means you can’t join).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study compares two types of scans—one that uses a special tracer (PET/CT) and another that uses contrast dye (CT)—to see how well they find breast cancer that has spread to other parts of the body. It may help find the best way to spot distant metastases early.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.